Welcome to our dedicated page for Ionq SEC filings (Ticker: IONQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Quantum computing promises transformative returns, yet IonQ’s SEC documents can read like a physics dissertation. Locating R&D burn rates, deciphering option grants, or spotting dilution warnings inside a single IonQ annual report 10-K simplified often takes hours. Stock Titan eliminates that pain. Our AI delivers IonQ SEC filings explained simply, showing the numbers and milestones without the math PhD.
Every time IonQ hits the EDGAR tape, we post the filing within seconds and pair it with machine-written context. Need the next IonQ quarterly earnings report 10-Q filing or an IonQ 8-K material events explained? It’s already summarized. Want alerts the moment a director sells shares? Our feed of IonQ Form 4 insider transactions real-time keeps you ahead. Below you’ll find:
- 10-K & 10-Q breakdowns highlighting cash runway, government contract backlog, and qubit roadmaps.
- Form 4 dashboards for IonQ insider trading Form 4 transactions and IonQ executive stock transactions Form 4.
- Proxy statement insights detailing IonQ proxy statement executive compensation.
- Instant notes on 8-K releases, mergers, or financing updates.
Use these AI summaries to compare quarter-over-quarter progress, monitor insider sentiment, or share concise takeaways with clients. Whether you’re modeling cash needs or validating strategic milestones, understanding IonQ SEC documents with AI turns dense disclosures into actionable clarity. Save time, catch details others miss, and rely on our IonQ earnings report filing analysis to stay informed about the company pushing quantum boundaries.
IonQ, Inc. prospectus supplement (Form 424B7) describes registration of shares by selling stockholders and methods for secondary sales, including over-the-counter, privately negotiated or exchange transactions, and refers readers to the Plan of Distribution on page S-13 for details. The document states that directors and officers are not subject to lock-up agreements and therefore, subject to securities laws, may sell shares at any time after September 5, 2025. It incorporates prior SEC filings by reference, including a Form 10-Q for the quarter ended June 30, 2025 filed on August 6, 2025, a 10-K filed February 26, 2025, and an 8-A filed November 10, 2020. The supplement references the company’s QCaaS offering and lists the corporate website https://ionq.com (website content not part of the prospectus).
Insider transactions by Director Inder M. Singh at IonQ (IONQ)
On 08/13/2025 Inder M. Singh executed multiple option-related transactions and a sale. He acquired 33,570 shares at $12.93, 2,050 shares at $5.72, and 14,860 shares at $13.53 through option-related actions. On the same date he sold 50,480 shares at a weighted-average price of $43.023. After these transactions the report shows the Reporting Person beneficially owned 5,513 shares. The filing notes all option shares were fully vested and exercisable as of the transaction date and that the sale price range was $42.97 to $43.16.
IonQ reported executive compensation changes affecting its Chief Executive Officer, Niccolo de Masi. The filing states Mr. de Masi was granted 485,319 RSUs effective August 13, 2025, which vest quarterly over three years, and his annual base salary was increased to $700,000. The filing also references performance share units (PSUs) in relation to the structure held by other senior employees and internal pay equity, noting strong performance and strategy initiatives as context for the awards.
IonQ director and CEO received a restricted stock unit award totaling 485,319 shares that vests over three years with quarterly vesting on March 10, June 10, September 10 and December 10, contingent on continued service. Following this grant the reporting person beneficially owns 1,197,306 shares. The award is reported as acquired at a $0 price because it is an RSU grant rather than a purchase. The filing documents the grant date and vesting schedule but does not include performance-based conditions; vesting is tied to continued service through each vesting date.
IonQ insider grant: The filing shows Paul Dacier, Chief Legal Officer and Corporate Secretary of IonQ (IONQ), received a restricted stock unit award for 109,197 shares on 08/13/2025 at a reported price of $0. After the award, the reporting person beneficially owns 118,629 shares. The RSUs vest over three years with 1/12th of the total award vesting quarterly on March 10, June 10, September 10 and December 10, subject to continued service through each vesting date. The form is a routine Section 16 disclosure of an equity award to an officer and contains no other transactions or derivatives.
IonQ Form 144 summary: This notice reports that 85,510 shares of IonQ common stock, acquired on 08/14/2025 upon vesting of equity awards, are proposed for sale through E-TRADE on or about 08/15/2025. The filing shows the company has 296,841,308 shares outstanding and places an aggregate market value on the planned sale of $3,523,868. The filer also disclosed multiple recent sales by the same person during June 2025 totaling several million shares with gross proceeds of approximately $228,225,951.06 across four transactions. The filer attests there is no undisclosed material adverse information.
IonQ, Inc. (IONQ) disclosure shows an insider, Inder Singh, proposes to sell 50,480 common shares through Morgan Stanley Smith Barney with an aggregate market value of $2,171,801.04. The shares were acquired by exercise of options under a registered plan (components: 2,050; 33,570; 14,860), and the proposed sale represents about 0.017% of the 296,837,796 shares outstanding. The filing lists prior sales in the past three months totaling 80,481 shares for gross proceeds of $3,117,335.44 (sales on 06/12/2025 and 08/01/2025). The notice includes the required representation that the seller is not aware of undisclosed material adverse information and references Rule 144 procedures.
IonQ, Inc. (IONQ) filed a prospectus supplement registering the resale by selling stockholders of up to 13,220,367 shares of common stock. The company will receive no proceeds from these sales. As of August 5, 2025, there were 296,841,308 shares outstanding and the last reported NYSE sale price was $42.02 per share on August 5, 2025.
The supplement discloses detailed selling stockholder positions (including institutional holders such as SK Square and USIT Holdco), escrowed shares related to the ID Quantique acquisition (including 902,160 escrowed shares), and a specified director/officer lock-up period from July 7, 2025 through September 5, 2025. The filing reiterates the companys recent operating losses of $209.1 million and $77.2 million for the six months ended June 30, 2025 and 2024, respectively, and an accumulated deficit of $892.8 million as of June 30, 2025.
IonQ, Inc. filed a prospectus supplement to its Form S-3ASR registration statement (File No. 333-285279) covering the resale by certain selling stockholders of 13,220,367 shares of common stock. A legal opinion from Paul, Weiss, Rifkind, Wharton & Garrison LLP is filed as Exhibit 5.1 and the firm's consent is included as Exhibit 23.1. The filing also includes the cover page interactive data file as Exhibit 104. The prospectus supplement and attached opinion are incorporated by reference into the registration statement to register the resale of the specified shares.
FAQ
What is the current stock price of Ionq (IONQ)?
What is the market cap of Ionq (IONQ)?
